Device Transactions Device companies finished 2014 raising $902 million during the fourth quarter, bringing the full-year financing total to $4 billion, remaining exactly flat from 2013's figure. ( Se
Exhibit 1 Top Alliances In January 2015 Potential Deal Value* *Potential deal value is the sum of up-front fees plus pre-commercialization money. Strategic Transactions Exhibit 2 Top Mergers & Acquisi
Company Changes BARR , John To: Angiotech Pharmaceuticals Inc. , CEO (October) From: Bausch & Lomb Inc., EVP, Pres., Global Surgical Phone: 604-221-7676 BARTHELEMY , Nicolas To: bioTheranos
Exhibit 1 Top Alliances In October 2014 Potential Deal Value *Potential deal value is the sum of up-front fees plus pre-commercialization money. Strategic Transactions Exhibit 2 Top Mergers & Acquisit